|Bid||0.00 x 1200|
|Ask||0.00 x 800|
|Day's Range||111.43 - 112.53|
|52 Week Range||101.24 - 142.60|
|Beta (5Y Monthly)||0.74|
|PE Ratio (TTM)||27.80|
|Earnings Date||Apr 18, 2022 - Apr 22, 2022|
|Forward Dividend & Yield||1.88 (1.73%)|
|Ex-Dividend Date||Jul 14, 2022|
|1y Target Est||127.91|
Two big U.S. retailers Walmart Inc and Target Corp said on Tuesday that supplies of baby formula were improving, months after the country faced acute shortages that had caused a panic among parents. Considering the still-existing supply constraints, Target said it will continue with the purchase restrictions both at its stores and online. The shortage that began due to pandemic-induced supply chain issues worsened in February when Abbott Laboratories, the biggest U.S. supplier, recalled some products and closed a manufacturing plant after reports of bacterial infections.
Walmart Inc, the largest U.S. retailer, said on Tuesday the availability of baby formula in its stores was improving months after the country experienced acute shortages that had caused a panic among parents. The shortage, initially spurred by pandemic-induced supply chain issues, was exacerbated in February when Abbott Laboratories, the biggest U.S. supplier of baby formula, recalled some products and closed a manufacturing plant on reports of bacterial infections. In response to the shortage, U.S. health regulators have since relaxed import policies and shipped in millions of cans of emergency supplies from companies such as Nestle SA and Reckitt Benckiser.
Thermo Fisher's (TMO) novel Applied Biosystems HIV-1 Genotyping Kit will aid in the global efforts to monitor the evolution of HIV.